Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2YNT30
Wed, 30.04.2025
Alzchem Group AG
Alzchem Group AG continues earnings growth in the first quarter of 2025; projects to expand nitroguanidine capacity launched
Group EBITDA grows by 10% to EUR 27.4 million with 4% lower revenue
Specialty chemicals are growth drivers
Forecast for further sales and EBITDA growth in 2025 confirmed
Trostberg, April 30, 2025 – Alzchem Group AG, a glo [ … ]
Fri, 21.03.2025
Alzchem Group AG
EQS-Media / 21.03.2025 / 13:52 CET/CEST
Alzchem Group AG: Successful Creatine Conference 2025 inspires international experts
The Alzchem Group brought together leading experts in creatine research in Munich from March 12 to 15, 2025. The Creatine Conference became a meeting place for scientists, health and nutrition experts, trade press and [ … ]
Mon, 17.03.2025
Alzchem Group AG
Alzchem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, March 17, 2025
Temporary Interruption of Share Repurchase Programme
Due to its Annual Shareholders Meeting to be held on May 8, 2025, Alzchem Group AG temporarily inter [ … ]
Mon, 03.03.2025
Alzchem Group AG
EQS-Media / 03.03.2025 / 17:12 CET/CEST
Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research
The Alzchem Group is once again bringing together the brightest minds in creatine research in 2025 – in the heart of Munich. From March 12 to 15, 2025, the Meliá Hotel will be transformed into a [ … ]
Fri, 28.02.2025
Alzchem Group AG
Alzchem Group AG achieves record EBITDA of EUR 105.3 million (+29.4%) in fiscal year 2024
Free cash flow climbs significantly by 42.3% to EUR 74.2 million
Dividend to be increased by 50% from EUR 1.20 to EUR 1.80
Further sales and EBITDA growth forecast for 2025
Trostberg, February 28, 2025 – Alzchem Group AG, a globally active specialty chemic [ … ]
Mon, 17.02.2025
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, February 17th, 2025
9th Interim Report
In the period from February 10th up to and including February 14th, 2025, a total of 8,730 shares of Alzchem Group AG were acquired as part of the sha [ … ]
Mon, 10.02.2025
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, February 10, 2025
8.Interim Report
In the period from February 3 up to and including February 7, 2025, a total of 7.217 shares of Alzchem Group AG were acquired as part of the share buyback [ … ]
Mon, 03.02.2025
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, February 3rd, 2025
7th Interim Report
In the period from January 27th up to and including January 31st, 2025, a total of 13,959 shares of Alzchem Group AG were acquired as part of the share [ … ]
Mon, 27.01.2025
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, January 27th, 2025
6th Interim Report
In the period from January 20th up to and including January 24th, 2025, a total of 7,659 shares of Alzchem Group AG were acquired as part of the share [ … ]
Mon, 20.01.2025
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, January 20th, 2025
5th Interim Report
In the period from January 13th up to and including January 17th, 2025, a total of 2,348 shares of Alzchem Group AG were acquired as part of the share [ … ]